Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles (EVs: Exosomes and Microvesicles): Research, Diagnostics and Therapeutics Applications

Rachel Tam's Biography



Rachel Tam, Senior Scientific Researcher, Oncology Biomarker Development, Genentech

Rachel Tam has been working in Genentech as senior scientific researcher for 7 years. She is a technical expert on multiple molecular biology technologies including qPCR, ddPCR and NGS. She has developed a high throughput multiplex microfluidics qPCR platform to detect mutations in fresh frozen, FFPE, TMA and cell free DNA samples from multiple clinical trials routinely. Recently, she has been developing ultra-sensitive assays utilizing ddPCR and NGS technologies to detect mutations from circulating tumor DNA, paving the way to develop personalized medicine for cancer patients.

Rachel Tam Image

Ultra-Sensitive Mutational Analysis in Cell-free DNA by Digital PCR and NGS Technologies

Thursday, 29 March 2018 at 11:30

Add to Calendar ▼2018-03-29 11:30:002018-03-29 12:30:00Europe/LondonUltra-Sensitive Mutational Analysis in Cell-free DNA by Digital PCR and NGS TechnologiesSELECTBIOenquiries@selectbiosciences.com

Circulating cell-free DNA (cfDNA) in plasma offers a non-invasive approach to monitor tumor molecular profiling in real-time at multiple time-points, detection of emerging genomic alterations associated with drug resistance and clarifying cancer prognosis and diagnosis of cancer recurrence or progression. We developed an ultra-sensitive droplet digital PCR (ddPCR) approach and molecular tagged NGS technologies to detect actionable cancer biomarkers in cfDNA.


Add to Calendar ▼2018-03-28 00:00:002018-03-29 00:00:00Europe/LondonExtracellular Vesicles (EVs: Exosomes and Microvesicles): Research, Diagnostics and Therapeutics ApplicationsSELECTBIOenquiries@selectbiosciences.com